Literature DB >> 8387417

Personality disorders in alcoholics and drug addicts.

C A DeJong1, W van den Brink, F M Harteveld, E G van der Wielen.   

Abstract

This report examines the prevalence of personality disorders among hospitalized alcoholics and polydrug addicts and the extent and nature of the overlap between different axis II disorders. Subjects were 178 alcoholics admitted to a diagnostic unit of an addiction treatment institute and 86 polydrug addicts admitted to the therapeutic community of the same institute. Substance abuse was diagnosed according to DSM-III-R, and patients were assessed with the Structured Interview for DSM-III Personality Disorders (SIDP). In the alcohol group, 78% of the patients had at least one personality disorder and the average number of personality disorders was 1.8 per patient. In the polydrug group, 91% of the patients met criteria for at least one personality disorder and the average number of personality disorders was 4.0 per patient. No single "addictive personality" emerged. These findings raise questions about the validity and usefulness of the distinction between axis I and axis II disorders in patients with substance use disorders, and do not lend support to the validity of the categorical classification of personality pathology.

Entities:  

Mesh:

Year:  1993        PMID: 8387417     DOI: 10.1016/0010-440x(93)90052-6

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  19 in total

1.  Personality disorders in early adolescence and the development of later substance use disorders in the general population.

Authors:  Patricia Cohen; Henian Chen; Thomas N Crawford; Judith S Brook; Kathy Gordon
Journal:  Drug Alcohol Depend       Date:  2007-01-16       Impact factor: 4.492

2.  Unidirectionality Between Borderline Personality Disorder Traits and Psychopathology in a Residential Addictions Sample: A Short-Term Longitudinal Study.

Authors:  Troy A Webber; Andrew M Kiselica; Alejandra Arango; Elizabeth Rojas; Michael C Neale; Marina A Bornovalova
Journal:  J Pers Disord       Date:  2015-01-06

3.  Heritability of MMPI-2 scales in the UCSF family alcoholism study.

Authors:  Ian R Gizer; Kimberley L Seaton-Smith; Cindy L Ehlers; Cassandra Vieten; Kirk C Wilhelmsen
Journal:  J Addict Dis       Date:  2010-01

4.  Two types of classification for male opioid dependence: identification of an opioid addict with depressive features.

Authors:  J Modestin; B Matutat; O Würmle
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-04-29       Impact factor: 5.270

5.  Personality disorders and cigarette smoking among adults in the United States.

Authors:  Michael J Zvolensky; Elizabeth F Jenkins; Kirsten A Johnson; Renee D Goodwin
Journal:  J Psychiatr Res       Date:  2010-12-17       Impact factor: 4.791

6.  The impact of borderline personality disorder on residential substance abuse treatment dropout among men.

Authors:  Matthew T Tull; Kim L Gratz
Journal:  Drug Alcohol Depend       Date:  2011-09-09       Impact factor: 4.492

7.  Personality disorders and retention in a therapeutic community for substance dependence.

Authors:  Douglas B Samuel; Donna M LaPaglia; Lisa M Maccarelli; Brent A Moore; Samuel A Ball
Journal:  Am J Addict       Date:  2011-10-04

8.  Aggressive temperament predicts ethanol self-administration in late adolescent male and female rhesus macaques.

Authors:  Megan N McClintick; Kathleen A Grant
Journal:  Psychopharmacology (Berl)       Date:  2016-09-14       Impact factor: 4.530

9.  Personality disorders in alcohol-dependent individuals: relationship with alcohol dependence severity.

Authors:  U W Preuss; M Johann; C Fehr; G Koller; N Wodarz; V Hesselbrock; W M Wong; M Soyka
Journal:  Eur Addict Res       Date:  2009-07-20       Impact factor: 3.015

10.  The relationship between concurrent substance use disorders and eating disorders with personality disorders.

Authors:  Christine Courbasson; Jacqueline M Brunshaw
Journal:  Int J Environ Res Public Health       Date:  2009-07-23       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.